Advertisement
Screener

Repare Therapeutics Inc. Patents: Applications Rejected

Repare Therapeutics Inc. Patent Applications Rejected

7 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2024-10-04: Application 18854213; Invention METHODS OF IDENTIFYING CANCERS HAVING A BIALLELIC LOSS OF FUNCTION MUTATION; Applicant Repare Therapeutics Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
  • 2024-09-18: Application 18888290; Invention COMBINATION TREATMENT OF CANCERS; Applicant Repare Therapeutics Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
  • 2023-12-12: Application 18537061; Invention USE OF ATR INHIBITORS IN COMBINATION WITH PARP INHIBITORS; Applicant Repare Therapeutics Inc.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2023-12-01: Application 18566492; Invention CRYSTALLINE FORMS, COMPOSITIONS CONTAINING SAME, AND METHODS OF THEIR USE; Applicant Repare Therapeutics Inc.; Status Abandoned -- Failure to Respond to an Office Action.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2024-10-0418854213METHODS OF IDENTIFYING CANCERS HAVING A BIALLELIC LOSS OF FUNCTION MUTATIONRepare Therapeutics Inc.Abandoned -- Incomplete Application (Pre-examination)US20250340943A1
Victoria RIMKUNAS
Dominik GLODZIK
Jorge Sergio REIS
Robert DABER
United States
United States
United States
Canada
2024-09-1818888290COMBINATION TREATMENT OF CANCERSRepare Therapeutics Inc.Abandoned -- Incomplete Application (Pre-examination)US20250090539A1
Michal Zimmermann
Anne Roulston
Julia Yang
Danielle Ulanet
Canada
Canada
United States
United States
2023-12-1218537061USE OF ATR INHIBITORS IN COMBINATION WITH PARP INHIBITORSRepare Therapeutics Inc.Abandoned -- Failure to Respond to an Office ActionUS20240350505A1
Michal Zimmermann
Anne Roulston
Maria Koehler
Canada
Canada
United States
DAVIS, BRIAN J
2023-12-0118566492CRYSTALLINE FORMS, COMPOSITIONS CONTAINING SAME, AND METHODS OF THEIR USERepare Therapeutics Inc.Abandoned -- Failure to Respond to an Office ActionUS20240294521A1
Angelos Dovletoglou
Robert Charles Livingston
Song Xue
Yuly Chiang Yu
Qi Gao
Saurin Raval
United States
United States
United States
United States
United States
United States
RAMOS LEWIS, JOSMALEN MILAGROS
2023-04-2718140302QUINAZOLINONES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAMERepare Therapeutics Inc.Abandoned -- Failure to Respond to an Office ActionUS20230348456A1
Janek SZYCHOWSKI
Bingcan LIU
Evelyne DIETRICH
Alexander PERRYMAN
Sheldon N. CRANE
Vouy Linh TRUONG
Abbas ABDOLI
Alexanne BOUCHARD
Canada
Canada
Canada
Canada
Canada
Canada
Canada
Canada
STOCKTON, LAURA LYNNE
2022-10-0617961103TRICYCLIC HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAMERepare Therapeutics Inc.Abandoned -- Failure to Respond to an Office ActionUS20230142913A1
Janek SZYCHOWSKI
Evelyne DIETRICH
Frédéric VALLÉE
Canada
Canada
Canada
VALLE, ERNESTO
2020-12-1117119512USE OF ATR INHIBITORS IN COMBINATION WITH PARP INHIBITORSRepare Therapeutics Inc.Abandoned -- Failure to Pay Issue FeeUS20210177856A1
Michal ZIMMERMANN
Anne ROULSTON
Maria KOEHLER
Canada
Canada
United States
DAVIS, BRIAN J